Increased BRD4-L and BRD4-S Promotes Chemotherapy Resistance in Ovarian Carcinoma
September 13, 2023
PRESS RELEASE: On September 12, 2023, a new research paper was published in Genes & Cancer, entitled, “Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma.” continue reading »